Mechanisms for ligand binding by serine-rich adhesins of Gram-positive pathogens

革兰氏阳性病原体富含丝氨酸的粘附素的配体结合机制

基本信息

  • 批准号:
    8788229
  • 负责人:
  • 金额:
    $ 75.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-01 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The serine-rich repeat (SRR) glycoproteins are a large family of adhesins found in many Gram-positive bacteria. These surface components are important virulence determinants for a broad range of human infections. GspB is an SRR adhesin of Streptococcus gordonii that mediates binding to human platelets through its interaction with the trisaccharide sialyl-T antigen (sTa) on the platelet receptor GPIb. This binding appears to be important for the pathogenesis of infective endocarditis, since mutagenesis of the GspB binding region results in decreased platelet binding in vitro, and reduced virulence in an animal model of this disease. Three properties of GspB binding may be highly important for the targeting of streptococci to the endocardium: affinity, selectivity, and fow enhancement. First, the binding of GspB to its platelet receptor is a high affinity interaction (KD 2.4 x 10-8 M). Second, GspB has a very selective binding spectrum, with sTa being its principal ligand. Third, GspB-mediated binding by bacteria to sTa is enhanced by levels of fluidic shear flow similar to those within the endovascular system. In combination, these three binding properties may target blood-borne streptococci to platelets immobilized at sites of endocardial injury (thereby initiating infection). GspB-mediated binding may also contribute to the subsequent formation of macroscopic endocardial lesions (vegetations) containing bacteria and platelets. This project seeks to define the molecular basis for GspB binding affinity, selectivity, and flow enhancement, and the relative importance of these properties for virulence. Aim 1 will examine how the molecular architecture of the GspB binding domain confers affinity and selectivity. We will determine the structure of the GspB binding region cocrystallized with sTa and related compounds, select key domains and residues for targeted mutagenesis, and examine the impact of these mutations on binding affinity and selectivity. Two GspB homologs (Hsa and SrpA) that differ in their binding properties will also be evaluated. Aim 2 will determine the structural features of GspB that contribute to flow-enhanced binding, and whether binding occurs via the formation of catch bonds. We will specifically examine the contribution of the serine-rich repeat domains of GspB in flow-enhanced binding. Aim 3 will assess the impact of ligand affinity, selectivity and flow-enhanced binding on the pathogenesis of infective endocarditis. Isogenic variants of S. gordonii strain M99 that differ in their ligand binding properties will be compared for relative virulence, using a well-established co-infection model of this disease. This project will provide significant insights into the structural basis for carbohydrate binding by this novel group of bacterial adhesins, as well as the mechanisms for streptococcal binding to human platelets. In addition, these studies could provide a basis for novel therapies for infective endocarditis that target SRR glycoprotein binding.
描述(由申请人提供):富含丝氨酸的重复(SRR)糖蛋白是许多革兰氏阳性细菌中发现的大型粘附素。这些表面成分是广泛的人类感染的重要毒力决定因素。 GSPB是Gordonii链球菌的SRR粘附蛋白,它通过与血小板受体GPIB上的Trisacharide siALlyl-T抗原(STA)相互作用,通过其与人血小板结合。这种结合对于感染性心内膜炎的发病机理似乎很重要,因为GSPB结合区域的诱变会导致体外血小板结合降低,并且在该疾病的动物模型中毒力降低。 GSPB结合的三种特性对于将链球菌靶向内膜心脏:亲和力,选择性和FOW增强可能非常重要。首先,GSPB与其血小板受体的结合是高亲和力相互作用(KD 2.4 x 10-8 m)。其次,GSPB具有非常选择性的结合频谱,而STA是其主要配体。第三,细菌与Sta的结合通过与血管内系统中的流体剪切流量相似,从而增强了GSPB介导的结合。结合起来,这三种结合特性可能靶向血液传播链球菌,使其在心内膜损伤部位固定的血小板(从而引发感染)。 GSPB介导的结合也可能有助于随后形成含细菌和血小板的宏观心内膜病变(植被)。该项目旨在定义GSPB结合亲和力,选择性, 和流动增强,以及这些特性对毒力的相对重要性。 AIM 1将检查GSPB结合域的分子结构如何同意亲和力和选择性。我们将确定与STA和相关化合物共结合的GSPB结合区域的结构,选择靶向诱变的关键域和残基,并检查这些突变对结合亲和力和选择性的影响。还将评估两个GSPB同源物(HSA和SRPA)在其结合特性上有所不同。 AIM 2将确定 GSPB的结构特征有助于流动增强结合,以及结合是否通过捕获键的形成发生。我们将专门研究GSPB富含丝氨酸的重复域在流动增强结合中的贡献。 AIM 3将评估配体亲和力,选择性和流动增强结合对感染性心内膜炎的发病机理的影响。使用该疾病的良好共同感染模型,将比较gordonii菌株M99的同基因变异。该项目将为这一新型细菌粘附素组以及链球菌与人血小板结合的机制提供对碳水化合物结合的结构基础的重要见解。此外,这些研究可以为靶向SRR糖蛋白结合的新型感染性心内膜炎提供基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

T M Iverson其他文献

T M Iverson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('T M Iverson', 18)}}的其他基金

Training in Pharmacological Sciences
药理学培训
  • 批准号:
    10625697
  • 财政年份:
    2023
  • 资助金额:
    $ 75.48万
  • 项目类别:
Engineered probes for sialoglycan detection
用于唾液酸聚糖检测的工程探针
  • 批准号:
    10438835
  • 财政年份:
    2020
  • 资助金额:
    $ 75.48万
  • 项目类别:
Engineered probes for sialoglycan detection
用于唾液酸聚糖检测的工程探针
  • 批准号:
    10653008
  • 财政年份:
    2020
  • 资助金额:
    $ 75.48万
  • 项目类别:
Engineered probes for sialoglycan detection
用于唾液酸聚糖检测的工程探针
  • 批准号:
    10266164
  • 财政年份:
    2020
  • 资助金额:
    $ 75.48万
  • 项目类别:
Molecular basis for arrestin-mediated signaling
抑制蛋白介导的信号传导的分子基础
  • 批准号:
    9324338
  • 财政年份:
    2016
  • 资助金额:
    $ 75.48万
  • 项目类别:
STRUCTURAL STUDIES OF TRANSMEMBRANE SIGNALING COMPLEXES AND NOVEL THERAPEUTIC AG
跨膜信号复合物和 NOVEL THERAPEUTIC AG 的结构研究
  • 批准号:
    8362282
  • 财政年份:
    2011
  • 资助金额:
    $ 75.48万
  • 项目类别:
Stabilization of Membrane Protein Signaling Complexes
膜蛋白信号复合物的稳定性
  • 批准号:
    8310115
  • 财政年份:
    2010
  • 资助金额:
    $ 75.48万
  • 项目类别:
Crystallographic Automation
晶体学自动化
  • 批准号:
    7793204
  • 财政年份:
    2010
  • 资助金额:
    $ 75.48万
  • 项目类别:
Stabilization of Membrane Protein Signaling Complexes
膜蛋白信号复合物的稳定性
  • 批准号:
    8519131
  • 财政年份:
    2010
  • 资助金额:
    $ 75.48万
  • 项目类别:
STRUCTURAL STUDIES OF TRANSMEMBRANE SIGNALING COMPLEXES AND NOVEL THERAPEUTIC AG
跨膜信号复合物和 NOVEL THERAPEUTIC AG 的结构研究
  • 批准号:
    8170283
  • 财政年份:
    2010
  • 资助金额:
    $ 75.48万
  • 项目类别:

相似国自然基金

基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
  • 批准号:
    32360190
  • 批准年份:
    2023
  • 资助金额:
    34 万元
  • 项目类别:
    地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
  • 批准号:
    82304698
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
  • 批准号:
    62302456
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
  • 批准号:
    32301185
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
  • 批准号:
    32370941
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Optical platform for functional longitudinal imaging of metabolite uptake in vivo
用于体内代谢物摄取功能纵向成像的光学平台
  • 批准号:
    10585764
  • 财政年份:
    2023
  • 资助金额:
    $ 75.48万
  • 项目类别:
Chip-Scale Intraoperative Optical Navigation with Immunotargeted Upconverting Nanoparticles
使用免疫靶向上转换纳米颗粒的芯片级术中光学导航
  • 批准号:
    10743477
  • 财政年份:
    2023
  • 资助金额:
    $ 75.48万
  • 项目类别:
"Extended dosing" immunization to enhance humoral immunity to next-generation vaccines
“延长剂量”免疫增强对下一代疫苗的体液免疫
  • 批准号:
    10638732
  • 财政年份:
    2023
  • 资助金额:
    $ 75.48万
  • 项目类别:
Augmenting cancer checkpoint immunotherapies via microbially-derived metabolites
通过微生物衍生的代谢物增强癌症检查点免疫疗法
  • 批准号:
    10506732
  • 财政年份:
    2023
  • 资助金额:
    $ 75.48万
  • 项目类别:
Protein Disulfide Bond Formation in the Reducing Environment of Cytoplasm
细胞质还原环境中蛋白质二硫键的形成
  • 批准号:
    10439311
  • 财政年份:
    2022
  • 资助金额:
    $ 75.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了